Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer
Clinical trial NCT01658462 · COMPLETED
Trial details
- NCT number
- NCT01658462
- Sponsor
- Centre Oscar Lambret
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2016-12-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.